SCHEMBL20380374

SCHEMBL20380374

CSc1nc(SC)c2ncc(C3(O)O[C@H](COCc4ccccc4)[C@@H](OCc4ccccc4)[C@@]3(C)CCc3ccccc3)n2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23278055 0.88 PDE2A (0.32) —
SCHEMBL12243144 0.88 PDE2A (0.30) —
SCHEMBL12393237 0.88 PDE2A (0.30) —
SCHEMBL13648927 0.83 PDE2A (0.34) —
SCHEMBL18788247 0.80 PDE2A (0.35) —
SCHEMBL13667496 0.80 PTPN1 (0.34) —
SCHEMBL12243146 0.79 HSPA5 (0.34) —
SCHEMBL20404007 0.79 PDE2A (0.32) —
SCHEMBL23278060 0.79 PDE2A (0.31) —
SCHEMBL23278061 0.78 BCHE (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10023600-B2 Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs GILEAD SCIENCES, INC. (US) 2018-07-17 — — US disclosed
Send feedback